CD BioSignal Introduces Apoptosis & Cell Death Solutions for Life Science Studies

December 31 19:17 2021
CD BioSignal introduces a comprehensive panel of apoptosis & cell death solutions to the life science research community.

New York, USA – December 31, 2021 – CD BioSignal, a US-based life science research product supplier and CRO, recently introduces a comprehensive panel of apoptosis & cell death solutions to the life science research community.

Cell death is a basic biological process that has been extensively explored in the past few decades. Active cell death (apoptosis, necroptosis, pyroptosis ferroptosis, alkaliptosis and oxeiptosis) is strictly regulated by signal pathways. Since cell death is closely related to disease, in-depth characterization of cell death events may reveal new therapeutic targets. CD BioSignal now provides a comprehensive research solution panel covering all aspects of cell death research, such as apoptosis, autophagic cell death, necrosis, mitotic catastrophe, and pyroptosis.

In multicellular organisms, cell death is the process by which cells stop functioning. It is essential for maintaining tissue homeostasis and eliminating potentially harmful cells. Although cell death may be caused by overwhelming damage, most of it is the result of specific signaling events. Characterized by different forms, apoptosis, autophagic cell death and necrosis are the three main types of cell death. They respond to specific stimuli through different but sometimes overlapping signal pathways.

Take the necrosis as an example. It is the type III cell death, and encompasses a variety of cell death processes, and is characterized by one thing in common: loss of plasma membrane integrity, followed by cytoplasmic leakage without chromatin condensation. In contrast, apoptosis and autophagic cell death are beneficial to the organism, while necrosis is usually harmful.

Previously, necrosis was thought to be an uncontrolled form of death caused by infection or injury, but now it is recognized that there is at least one way of active necrosis. In order to reflect the nature of regulatory necrosis, it is called “necroptosis”, in which receptor-interacting protein kinases 1 and 3 (RIP1 and RIP3) play a key role. In addition to RIP-dependent necrosis, there are other forms of necrosis signaling, however, none of them are fully characterized.

As a trusted CRO, CD BioSignal provides a comprehensive panel of solutions covering all aspects of life science research, including cell death. Its solutions for cell death research include but are not limited to Regulator Identification identifying gene regulators participating in a certain cell death signaling pathway, Regulator Characterization studying the molecular function of a certain regulator in cell death signaling pathways, Mechanism Study investigating into the mechanism of regulation of a certain regulator, and Cell Death Characterization identifying and characterizing the types of cell death under certain conditions.

“Cell signaling plays a central role in modern life science research. With advanced technologies and dedicated scientists, CD BioSignal offers various research solutions for studying cell death signaling pathways. Other related services such as Gene-based Services, Protein-based Services, Cell-based Services, and Pathway-based Services are also available at CD BioSignal,” said Kristy J. Morris, the marketing director at CD BioSignal.

Customers for more information about the apoptosis & cell death solutions, please visit CD BioSignal at https://www.cd-biosignal.com.

About CD BioSignal

CD BioSignal is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSignal is the one-stop shop devoted to researchers making advancements in signaling pathway studies.

Media Contact
Company Name: CD BioSignal
Contact Person: Kristy J. Morris
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.cd-biosignal.com